TEACH-PD Cluster Randomised Control

Targeted Education ApproaCH to Improve Peritoneal Dialysis Outcomes Cluster Randomised Controlled Trial (CRCT) Study

Response plan for novel coronavirus (COVID-19) – TEACH-PD

In response to the COVID-19 pandemic and resultant burden on clinicians and health system, the Trial Sponsors have implemented the following in the TEACH-PD trial in Australia and New Zealand:

  • Recommencement of recruitment of new patients at currently active sites once governance approval is granted.
  •  Active units will be offered refresher training as required in order to confidently resume consent and enrolment processes.
  • For units still seeking local approval, AKTN and University of Otago will continue to support this process and activate sites as they are approved and able.

The Sponsors will continue to monitor the situation and will take appropriate action at site, region and trial level as appropriate. We appreciate your commitment and valuable contribution to the TEACH-PD trial.

Please contact the TEACH-PD team if you would like to discuss further:
Australian sites: teachpd@uq.edu.au
New Zealand sites: teachpd.nz@otago.ac.nz

Principal Investigators:  Josephine Chow, Neil Boudville
Clinical Project Manager: Laura Robison (AKTN)
Clinical Research Associate: Andrea Valks, Ruth Stastny
Trial Number: AKTN 17.03
Population: About 46 sites and all incident PD patients
 
Intervention: PD training using TEACH-PD training modules
Follow-up: 2 years
Primary outcome: Time to the first occurrence of any PD-related infection (exit site infection, tunnel infection or peritonitis
Status:  Recuitment Open
Target Recruitment: 1500 participants across Australia and New Zealand
 
Trial Summary
In Australia and New Zealand PD-related infections are the major causes of PD technique failure. The burden of PD-related infections, such as recurrent or severe exit site infections and peritonitis, is both high and unacceptably variable between different centres, with the variation appearing to be driven by centre-related factors rather than patient-related factors. Some of the centre-specific disparity in outcomes, including peritonitis rates, has been attributed to variable attention paid by centres to potentially modifiable peritonitis risk factors, including training practices. The TEACH-PD training modules have been developed by a core group of renal nurses from the HOME Network (THN) in conjunction with senior medical clinicians from the Australasian Kidney Trials Network (AKTN), eLearning curriculum developers, consumer representatives, and education experts, in line with the ISPD guidelines, utilising modern adult learning principles and best practice eLearning techniques. The modules will be implemented at PD units in Australia and New Zealand to formally evaluate whether, compared with standard care, a standardised training curriculum will reduce the rate of PD- related infections and improve technique survival, resulting in better outcomes for patients receiving PD and significant cost-savings to the community.
The study has already received funding from the BEAT-CKD Program, ISPD, Baxter, QLD Health, Metro South Health Research Support Scheme Research Fund, Medical Council Medical Research Future Fund Rare Cancers, Rare Diseases and Unmet Need Initiative